Dedicated to strengthening the role of public health
by improving education and training
of public health professionals
for both practice and research
Remember me

The Association of Schools of Public Health in the European Region (ASPHER)

ASPHER is the key independent European organisation dedicated to strengthening the role of public health by improving education and training of public health professionals for both practice and research.
Home » ASPHER Programme for Public Health Competencies » COVID-19 Task Force


25 Nov 2021
ASPHER's Statement:  Waive Vaccine Intellectual Property Rights Now has been adopted by the World Federation of Public Health Associations (WFPHA) and the Global Network for Academic Public (GNAPH) Read the Summary statement below and...
24 Nov 2021
Download the October - November ASPHER Newsletter here! We open our newsletter this month with a photo referencing the children’s game of Ring around the Rosie. It is debated whether or not the rhyme associated with the game has its origin in...
10 Nov 2021
Since March 2021, the world’s leaders have expressed a desire to “build back better,” reflecting a desire to see an enhanced post-pandemic world and the need to improve and protect health by being better prepared to respond to future...

COVID-19 Task Force

ASPHER has convened a COVID-19 Task Force to facilitate relevant networking necessary to respond to the current emergency. If you wish to participate in the ASPHER COVID-19 Taskforce, please contact Robert at:

COVID 19 Task Force Initatives

ASPHER COVID-19 Statement: ASPHER statement on the novel coronavirus disease (COVID-19) outbreak emergency

ASPHER Public Health Erosion Statement: The Association of Schools of Public Health in the European Region (ASPHER) Statement on the Erosion of Public Health Systems

The Role of European Schools and University Departments of Public Health in the 2020 COVID-19 Response: ASPHER Survey Report

COVID-19 Situation Reporting across Europe

**New** Country Situation Reporting webpage (updated weekly)

COVID-19 Third Wave: Summer 2021

Déjà vu? Planning for the Covid-19 third wave and planning for the winter. ASPHER Statement

COVID-19 is at a Crossroads in Europe in Summer 2021: Risks of the Third Wave and the need to anticipate scenarios considering pitfalls. ASPHER Report

Inequalities and Vulnerable populations subgroup webplatform  

**New** The impact of COVID-19 on intimate partner violence in Europe

ASPHER Report on Homelessness and Pandemic Measures: COVID-19 and People Experiencing Homelessness: Reported Measures Implemented in the European Region during the Pandemic

ASPHER Statement on vaccination in Palestine: The Right to COVID-19 Vaccination must be extended to Palestinians

Prisons and COVID-19 Report: Prisons and COVID-19 policies: the need for collaborative and participatory health interventions

Inequalities and Vulnerable populations Statement:  First Statement of the ASPHER COVID-19 Task Group on Health Inequalities and Vulnerable Populations

Inequalities and Vulnerable populations Report: Ethical and Professional Guidance for Public Health Academics and Professionals: How should we evaluate Country-level Rapid Reviews of Pandemic Impacts on Health Inequalities and Vulnerable population groups? 

Inequalities Basic Terms: What is Inequality? Basic Health Inequality Concepts for Understanding the COVID-19 Pandemic 

ASPHER Comment on PHRI Statement: ASPHER Comment on the Physicians for Human Rights-Israel (PHRI) Satement of the 7 Aprl 2020 | Statement of PHRI calling on Israel to take measures to save lives

Children's Issues

ASPHER Statement: Vaccinating Children and Young People: What are the issues?

ASPHER Statement: Children and COVID-19 Closing or keep opening the schools: The consequences

ASPHER Technical Report: Children and COVID-19 Closing or keep opening the schools: The consequences

Infographic: COVID-19 School Challenges

ASPHER Statement on Children's Issues: First Statement of ASPHER on COVID-19 and its Impacts on Children During and After the Pandemic

Mask Use by Children StatementASPHER Statement on the Use of Masks by Children


**New** ASPHER Statement: A vaccine waiver now

**New** Full statement on the proposal for a waiver of the Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement), and related vaccine equity issues

ASPHER Statement: Vaccinating Children and Young People: What are the issues?

The Importance of Health Communication during Emergencies: The Mix-and-Match Question. (English)

Frequently Asked Questions: FAQs about the Covid-19 Vaccine

ASPHER Statement in response to new CDC guidelines for vaccinated indivduals: ASPHER Statement on the Abolition of Mandatory Prevention Measures in the US for Fully Vaccinated Individuals

Two months after the European Medicines Agency (EMA) ruling on the safety of the Astra-Zeneca Covid-19 (Vaxzevria®) vaccine, ASPHER provides an update. (English)

ASPHER welcomes European Medicines Agency judgement on the safety of AstraZeneca Covid-19 vaccine. (English) (French)

Vaccine Internationalism Statement: Towards ‘vaccine internationalism’ an ASPHER statement on the need for an equitable and coordinated global vaccination approach to effectively combat COVID-19

Vaccine Priority and Planning Statement: ASPHER statement on the need for a coordinated, professional approach to policy and planning for COVID-19 vaccination roll-out

ASPHER Statement on vaccination in Palestine: The Right to COVID-19 Vaccination must be extended to Palestinians

Vaccine nationalism will hinder our ability to effectively combat covid-19 (BMJ Opinion) January 2021: We need an equitable and coordinated global approach to Covid-19 vaccination

ASPHER COVID-19 Vaccine Statement (BMJ Opinion); November 2020: Covid-19 vaccines-where are the data?

ASPHER COVID-19 Vaccine Statement (BMJ Opinion); September 2020: Vaccines for Covid-19: reasons for hope, but first for concern

Planning for a Second Wave Pandemic, Planning for Winter

subgroup webplatform

Planning for Winter Report: Planning for a second wave pandemic of COVID-19 and planning for winter

COVID-19 Lockdown Illnesses Report: What are the COVID-19 Lockdown-induced illnesses and why should European public health systems be investigating their epidemiology, treatment, and prevention?

COVID-19 Herd Immunity Report:  Getting Through the Pandemic in Europe in the Winter of 2020/21 The Misuse of COVID-19 Herd Immunity Argument

Vitamin D and COVID-19 Report: Vitamin D for Preventive and Adjunct Therapy for Mitigation of Early Stages of Severe Acute Respiratory Syndrome due to COVID-19 (SARS-CoV-2)

De-escalation planning/regulations in aftermath: webplatform on the state of the emergence from lockdown and recovery

COVID-19 lockdown rules in selected European countries (30.12.2020) (including meeting indoors, meeting outdoors, pubs and bars, restaurants, entertainment, close contact retail, non-essential shops, universities, schools, public services, work places, travel in and out, wedding/funeral, places of worship, vaccination) (pdf version)

School Reopening: 

Phase 2: January 2021 Rapid Response Survey Report

Phase 1: July 2020 Rapid Response Survey Report 


Handbook on Basic Epidemiological TermsHow to Count Illness: Basic epidemiological concepts for understanding the COVID-19 epidemic 

Updated 2nd Edition of How to Count Illness now available! Now in Italian!

Spanish and Romanian Translations now available.


Statement on New Mask Use Regulations: Statement on the New Recommendations for the Use of Masks Following the Spread of SARS-Cov-2 Variants

Masks Use Statement: ASPHER Statement on the Strategic Use of Masks 

Masks Use Report: Technical Report: Strategic use of masks as an element of a non-pharmaceutical measures set for a pandemic 

Masks Use Infographic: Infographic: Protocol for Strategic Use of Masks 

Press Release

Mask Use by Children StatementASPHER Statement on the Use of Masks by Children (Updated 9 July 2020 and new translations)


COVID-19 Testing 3rd Statement: Lateral Flow Antigen Tests - not a panacea for freedom from the pandemic

Educational Testing Video:  Fixed Cut-off? Think Again...

COVID-19 Testing 2nd Statement: COVID-19 testing from a public health perspective: Selection of test, cut-off and sampling scheme should depend on the purpose of testing

COVID-19 Testing Statement: ASPHER Statement on the COVID-19 Testing 

COVID-19 Testing Report: Technical Report: COVID-19 testing: A reflection on test accuracy in the real world 

COVID-19 Testing Decision Tree: COVID-19 Testing decision tree

Surveillance and Tracking Applications

Surveillance/Tracking Apps Statement: ASPHER Statement – Contact Tracing Apps

Surveillance/Tracking Apps Report: Policy Report: Contact Tracing Apps for COVID-19 - An Overview of the European Region

Surveillance/Tracking Apps Basic Terms: Repository of Basic Technical Terms 

Young Professionals Group

Call for Applications: ASPHER Young Professionals Programme

ASPHER’s Young Professionals Programme (YPP) is looking for new members to join in the summer of 2021!

Applications are now closed.

Learn more here!

The ASPHER COVID-19 Taskforce is looking for motivated young researchers, students and alumni from our member schools who would be interested in contributing to time to specific topics related to the COVID-19 Pandemic. Depending on their interest, this may be by working with the Young Professional sub-group to produce short 1000-word reports or more in depth collaboration with other sub-groups on longer ASPHER reports and position papers. Please disseminate this information to your best and brightest students and alumni and ask them to contact Ines Siepmann

The ASPHER COVID-19 Task Force is teaming up with the COVID-19 Health System Response Monitor (HSRM) to provide rapid reporting for Cross Country Analysis on policy responses to the COVID-19 crisis. HSRM is a joint undertaking of the WHO Regional Office for Europe, the European Commission, and the European Observatory on Health Systems and Policies.

Task Force Members

Chair: John MIDDLETON, ASPHER President


Lukasz BALWICKI, Medical University of Gdansk, POLAND

Henrique BARROS, University of Porto, PORTUGAL

Robert BUCKINGHAM, University of Michigan-Flint, USA 


Kasia CZABANOWSKA, Maastricht University, THE NETHERLANDS

Nadav DAVIDOVITCH, Ben Gurion University of the Negev, ISRAEL

Jeannette DE BOER, NSPOH, Groningen, NETHERLANDS 

Alberto FERNÁNDEZ, EASP, Granada, SPAIN 

Anders FOLDSPANG, Emeritus, Aarhus University, DENMARK

Manfred S. GREEN, University of Haifa, ISRAEL

Polychronis KOSTOULAS, University of Thessaly, GREECE

Jutta LINDERT, Emden-Leer University of Applied Sciences, GERMANY

Henrique LOPES, Catholic University, Lisbon, PORTUGAL 

Jose M MARTIN-MORENO, University of Valencia, SPAIN 

Amanda MASON-JONES, University of York, UK

Kai MICHELSEN, University of Applied Sciences, Fulda, GERMANY


Vasco Ricoca PEIXOTO, National SPH Lisbon NOVA, PORTUGAL

Alena PETRAKOVA, Palacky University Olomouc, CZECHIA

Vladimir PRIKAZSKY, National Institute of Public Health,  CZECHIA

John REID, University of Chester, UK


Mohamud SHEEK-HUSSEIN, United Arab Emirates University, UAE 

Carlo SIGNORELLI, University Vita-Salute San Raffaele, Milan, ITALY

Judit SIMON, Medical University of Vienna, AUSTRIA

Natia SKHVITARIDZE, School of Health Sciences, University of Georgia, GEORGIA